291 related articles for article (PubMed ID: 10401972)
1. Weight change in adolescents who used hormonal contraception.
Risser WL; Gefter LR; Barratt MS; Risser JM
J Adolesc Health; 1999 Jun; 24(6):433-6. PubMed ID: 10401972
[TBL] [Abstract][Full Text] [Related]
2. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
Moore LL; Valuck R; McDougall C; Fink W
Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
[TBL] [Abstract][Full Text] [Related]
4. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
5. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
Paiva LC; Pinto-Neto AM; Faundes A
Contraception; 1998 Dec; 58(6):351-5. PubMed ID: 10095971
[TBL] [Abstract][Full Text] [Related]
6. Forearm bone density in users of Depo-Provera as a contraceptive method.
Bahamondes L; Perrotti M; Castro S; Faúndes D; Petta C; Bedone A
Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
[TBL] [Abstract][Full Text] [Related]
7. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
8. Progestin-only contraceptives: effects on weight.
Lopez LM; Ramesh S; Chen M; Edelman A; Otterness C; Trussell J; Helmerhorst FM
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008815. PubMed ID: 27567593
[TBL] [Abstract][Full Text] [Related]
9. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
Virutamasen P; Wangsuphachart S; Reinprayoon D; Kriengsinyot R; Leepipatpaiboon S; Gua C
Asia Oceania J Obstet Gynaecol; 1994 Sep; 20(3):269-74. PubMed ID: 7811192
[TBL] [Abstract][Full Text] [Related]
10. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method.
Bonny AE; Ziegler J; Harvey R; Debanne SM; Secic M; Cromer BA
Arch Pediatr Adolesc Med; 2006 Jan; 160(1):40-5. PubMed ID: 16389209
[TBL] [Abstract][Full Text] [Related]
11. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
[TBL] [Abstract][Full Text] [Related]
12. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
Pardthaisong T; Gray RH; McDaniel EB
Lancet; 1980 Mar; 1(8167):509-12. PubMed ID: 6102234
[TBL] [Abstract][Full Text] [Related]
13. Adolescent satisfaction with postpartum contraception and body weight concerns.
Hellerstedt WL; Story M
J Adolesc Health; 1998 Jun; 22(6):446-52. PubMed ID: 9627814
[TBL] [Abstract][Full Text] [Related]
14. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
Harel Z; Biro FM; Kollar LM
J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
[TBL] [Abstract][Full Text] [Related]
15. Progestin-only contraceptives: effects on weight.
Lopez LM; Edelman A; Chen M; Otterness C; Trussell J; Helmerhorst FM
Cochrane Database Syst Rev; 2013 Jul; 7(7):CD008815. PubMed ID: 23821307
[TBL] [Abstract][Full Text] [Related]
16. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
Potter LS; Dalberth BT; Cañamar R; Betz M
Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
[TBL] [Abstract][Full Text] [Related]
17. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
Lei ZW; Wu SC; Garceau RJ; Jiang S; Yang QZ; Wang WL; Vander Meulen TC
Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
[TBL] [Abstract][Full Text] [Related]
18. Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate.
Mangan SA; Larsen PG; Hudson S
J Pediatr Adolesc Gynecol; 2002 Apr; 15(2):79-82. PubMed ID: 12057528
[TBL] [Abstract][Full Text] [Related]
19. Bone density in long term users of depot medroxyprogesterone acetate.
Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
[TBL] [Abstract][Full Text] [Related]
20. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception.
Clark MK; Dillon JS; Sowers M; Nichols S
Int J Obes (Lond); 2005 Oct; 29(10):1252-8. PubMed ID: 15997247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
